title: Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
authors.forename: A K
authors.initials: AK
authors.lastname: Bhalla
authors.forename: M
authors.initials: M
authors.lastname: Samaranayaka
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D017410:Practice Guidelines as Topic
chemical_list: D018501:Antirheumatic Agents